Silva Paul M insider trades
Silva Paul M has filed 10 Form 4s with the SEC that we hold, for Nurix Therapeutics, Inc. (NRIX) (Director) and Rapport Therapeutics, Inc. (RAPP) (Director). Across all of them we count 1 purchase worth $99.6K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($99.6K) and 0 sales ($0). The largest single trade was a purchase of 3,680 shares of Rapport Therapeutics, Inc. worth $99.6K, dated 2026-10-22. The first filing on our record is dated 2021-10-04 and the latest 2026-10-22.
Nurix Therapeutics, Inc. (NRIX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rapport Therapeutics, Inc. (RAPP)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-22 | P, purchase reported on Form 4 | 3,680 | $99.6K | 2026-10-22 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1446372) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
